证券代码：603363 证券简称：傲农生物 公告编号：2026-002 福建傲农生物科技集团股份有限公司 关于部分限售股上市流通的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次股票上市类型为其他股份（重整投资转增股份）；股票认购方式为网 下，上市股数为84,448,385股。 本次股票上市流通总数为84,448,385股。 2024 年 11 月 5 日，福建省漳州市中级人民法院（以下简称"漳州中院"或"法 院"）裁定受理债权人对公司的重整申请，并指定上海市锦天城律师事务所担任公 司管理人（以下简称"管理人"），具体内容详见公司于 2024 年 11 月 6 日披露的 《关于法院裁定受理公司重整及指定管理人暨公司股票被叠加实施退市风险警示 的公告》（公告编号：2024-193）。 2024 年 12 月 9 日，漳州中院裁定批准《福建傲农生物科技集团股份有限公司 重整计划》，并终止公司重整程序，具体内容详见公司于 2024 年 12 月 11 日披露 的《关于公司重整计划获得法院裁定批准的公告》 ...

Core Viewpoint - Aonong Biological announced the addition of litigation (arbitration) amounting to 2,077.613 million yuan since July 7, 2025, with an uncertain impact on the company's profits due to ongoing cases [1] Group 1 - The total amount of new litigation (arbitration) is 2,077.613 million yuan [1] - The amount of unresolved cases is 1,236.807 million yuan, while the resolved cases amount to 840.806 million yuan [1] - The impact on the company's current and future profits remains uncertain due to some cases not yet being heard or concluded [1]

国泰海通证券股份有限公司 关于福建傲农生物科技集团股份有限公司 部分限售股上市流通的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"、"财务顾问"）作为福 建傲农生物科技集团股份有限公司（以下简称"傲农生物"、"公司"）破产重整 业务聘请的财务顾问，根据《中华人民共和国公司法》《中华人民共和国证券法》 《上海证券交易所上市公司自律监管指引第 13 号——破产重整等事项》等有关 法律法规和规范性文件要求，对傲农生物重整投资人受让资本公积转增的部分限 售股份将上市流通事项进行了核查，具体情况如下： 一、关于本次限售股上市流通事项 （一）本次限售股上市类型 傲农生物本次上市流通的限售股类型为财务投资人在公司重整中取得的转 增股份。 2024 年 11 月 5 日，福建省漳州市中级人民法院（以下简称"漳州中院"或 "法院"）裁定受理债权人对公司的重整申请，并指定上海市锦天城律师事务所 担任公司管理人（以下简称"管理人"），具体内容详见公司于 2024 年 11 月 6 日 披露的《关于法院裁定受理公司重整及指定管理人暨公司股票被叠加实施退市风 险警示的公告》（公告编号：2024-193）。 2024 年 12 ...

证券代码：603363 证券简称：傲农生物 公告编号：2026-003 福建傲农生物科技集团股份有限公司 关于新增涉及诉讼、仲裁事项的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 根据《上海证券交易所股票上市规则》有关规定，福建傲农生物科技集团股 份有限公司对公司及下属控股子公司（简称"公司"）2025 年 7 月 7 日至今新 增涉及诉讼、仲裁事项进行了统计，新增涉及的诉讼、仲裁案件共计 149 笔，新 增涉及的诉讼、仲裁金额合计 20,776.13 万元，占公司最近一期经审计净资产的 8.10%。 现集中披露 2025 年 7 月 7 日至今新增相关诉讼、仲裁案件的基本情况如下： 一、本次披露的新增诉讼、仲裁案件基本情况 公司 2025 年 7 月 7 日至今新增诉讼（仲裁）金额 20,776.13 万元。其中，公 司及下属子公司作为原告（申请人）涉及的诉讼、仲裁事项金额为 5,221.07 万元， 作为被告（被申请人）或第三人涉及的诉讼、仲裁事项金额为 15,555.06 万元； 尚未结案的诉讼、 ...

南财智讯1月23日电，傲农生物公告，本次上市流通的限售股总数为8444.84万股，上市流通日期为2026 年1月29日。 ...

傲农生物公告称，2025 年 7 月 7 日至今，公司及下属控股子公司新增诉讼、仲裁案件 149 笔，涉诉金 额 20776.13 万元，占最近一期经审计净资产的 8.10%。其中，公司及子公司作为原告（申请人）涉诉 金额 5221.07 万元，作为被告（被申请人）或第三人涉诉 15555.06 万元。未结案案件涉诉金额 12368.07 万元，已结案涉诉 8408.06 万元。因部分案件未开庭、未结案或未执行完毕，对公司利润影响不确定。 ...

傲农生物公告称，此次上市流通的限售股为财务投资人在公司重整中取得的转增股份。2024年12月为执 行重整计划，公司共计转增17.35亿股。2024年12月27日，8.47亿股有限售条件流通股划转至重整投资人 证券账户。现55名股东合计8444.84万股限售股锁定期已满，将于2026年1月29日上市流通。上市后，有 限售条件的流通股减至4.74亿股，无限售条件的流通股增至21.29亿股，总股本保持26.03亿股不变。 ...

Group 1 - The feed sector experienced a decline of 0.29% on January 23, with Zhongchong Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 4136.16, up 0.33%, while the Shenzhen Component Index closed at 14439.66, up 0.79% [1] - Key stocks in the feed sector showed varied performance, with Tianma Technology rising by 2.94% to a closing price of 16.13, while Zhongchong Co., Ltd. fell by 1.55% to 49.52 [2] Group 2 - The feed sector saw a net outflow of 70.64 million yuan from institutional investors, while retail investors had a net inflow of 90.51 million yuan [2] - The trading volume and turnover for major stocks in the feed sector varied, with major stocks like Tianma Technology and Haida Group showing significant trading activity [3] - The net inflow and outflow of funds for specific stocks indicated a mixed sentiment among investors, with some stocks like Haida Group experiencing a net inflow of 13.67 million yuan from institutional investors [3]

Core Insights - In December 2025, 16 major pig farming companies in China achieved a total sales volume of 17.72 million pigs, marking a year-on-year increase of 3.51% and a month-on-month increase of 7.15% [1][5][6] - The total revenue for these companies in December was 22.104 billion yuan, reflecting a year-on-year decline of 26.85% but a month-on-month increase of 4.87% [1][5][11] Sales Volume Analysis - The leading company, Muyuan Foods, sold 6.98 million pigs in December, while Wens Foodstuffs and New Hope reported sales of over 1.8 million pigs each [1][6] - Jin Xin Nong and Zhengbang Technology experienced significant sales growth, with increases exceeding 70% year-on-year, while four companies, including Muyuan Foods and Tangrenshen, saw declines of over 10% [1][6][10] Revenue Analysis - The revenue figures for December showed that Jin Xin Nong and Zhengbang Technology had revenue growth rates exceeding 20%, while four companies, including Zhenghong Technology and Tiankang Biological, reported revenue declines of over 30% [1][11] - Muyuan Foods generated 9.667 billion yuan in revenue for December, down 36.06% year-on-year, while Wens Foodstuffs and New Hope also reported declines of 11.38% and 10.75%, respectively [10][12] Price Trends - The average transaction price for pigs in the national market fluctuated around 15 yuan per kilogram in early 2025, dropping to a low of 11.05 yuan per kilogram in the latter half of the year [2]

Market Overview - The feed sector experienced a decline of 0.69% on January 21, with Aonong Biological leading the drop [1] - The Shanghai Composite Index closed at 4116.94, up 0.08%, while the Shenzhen Component Index closed at 14255.12, up 0.7% [1] Individual Stock Performance - Jin Xin Nong (002548) closed at 6.56, up 2.34% with a trading volume of 399,800 shares and a transaction value of 261 million [1] - Petty Holdings (300673) closed at 19.46, up 1.62% with a trading volume of 82,200 shares and a transaction value of 159 million [1] - Aonong Biological (603363) closed at 4.27, down 1.84% with a trading volume of 430,600 shares and a transaction value of 184 million [2] - Other notable declines include Tian Kang Biological (002100) down 1.26% and Hai Da Group (002311) down 1.17% [2] Capital Flow Analysis - The feed sector saw a net outflow of 95.94 million from institutional investors, while retail investors had a net inflow of 63.31 million [2] - The capital flow for individual stocks shows Jin Xin Nong with a net inflow of 21.61 million from institutional investors, while Aonong Biological had a net outflow of 1.32 million [3] - Petty Holdings experienced a net outflow of 1.99 million from institutional investors but a net inflow of 6.27 million from retail investors [3]